Skip to main content

Vendor Drug Program

Keyword search

Top nav menu

About
Providers
Formulary
Resources

Click here to get the latest information on the coronavirus (COVID-19) from Texas HHS.

Main navigation

About
Providers
Formulary
Resources

Breadcrumb

Home
About
Current News
News Archive

News Archive

February 16, 2022

Oxbryta Prior Authorization Criteria Updates Scheduled for April 5
Cytokine and CAM Antagonists Criteria Updates Scheduled for April 5
Updates to Phosphate Binder Prior Authorization Criteria Scheduled for April 5

February 3, 2022

January 2022 Drug Utilization Review Board Meeting Summary

January 24, 2022

January 2022 Preferred Drug List Now Available

January 21, 2022

2021-22 Respiratory Syncytial Virus (RSV) Season Ends February 1

January 12, 2022

Pfizer-BioNTech COVID-19 Booster Update
Temporary Change in PDL Status for Tetracyclines Drug Class, Effective January 11

January 6, 2022

Merck Oral COVID-19 drug, Molnupiravir, Added to Formulary

January 3, 2022

You Can Report Drug Shortages to HHSC

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Filter news by type

right column

Resources

THMP: Provider enrollment news
HHSC email notification service

Texas.gov
Website Policy
Notice of Privacy Practices
Accessibility

Statewide Search
File-Viewing Information
Homeland Security

Compact with Texans
Contact Us
Report Fraud, Waste and Abuse

© Copyright 2014-2022. Texas Health & Human Services Commission. All rights reserved.

About
Providers
Formulary
Resources